Skip to main content

and
  1. No Access

    Article

    Kidney enlargement effect of angioplasty for nonatherosclerotic renovascular disease: reversibility of ischemic kidney

    Renal artery stenosis causes kidney ischemia, reducing the size of the affected kidney, which eventually results in atrophy. Although renal atrophy is considered irreversible, resolution of the ischemia occasi...

    Tomoyuki Iwasaki, Eikan Mishima, Takehiro Suzuki, Koichi Kikuchi in Hypertension Research (2020)

  2. Article

    Open Access

    Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial

    We report the first protocol for a multicenter, randomized comparison study to compare the efficacies of periodontal scaling and root-planing treatment against that of tooth-brushing treatment for nonalcoholic...

    Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu, Takashi Kobayashi, Takeo Kurihashi in Trials (2020)

  3. Article

    Open Access

    Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease

    Diabetic kidney disease is a major cause of renal failure that urgently necessitates a breakthrough in disease management. Here we show using untargeted metabolomics that levels of phenyl sulfate, a gut microb...

    Koichi Kikuchi, Daisuke Saigusa, Yoshitomi Kanemitsu in Nature Communications (2019)

  4. No Access

    Article

    Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot study

    The purpose of this study was to clarify the predictive clinical characteristics of therapy switching from sitagliptin to dulaglutide in patients with type 2 diabetes mellitus.

    Tomoyuki Iwasaki, Takaomi Kessoku, Takuma Higurashi in Diabetology International (2018)

  5. Article

    Open Access

    Applications of reconstituted inflammasomes in a cell-free system to drug discovery and elucidation of the pathogenesis of autoinflammatory diseases

    The inflammasome, typically consisting of a Nod-like receptor, apoptosis-associated speck-like protein, and pro-caspase-1, has recently been identified as a huge intracellular complex, which plays a crucial ro...

    Naoe Kaneko, Tomoyuki Iwasaki, Yuki Ito, Hiroyuki Takeda in Inflammation and Regeneration (2017)

  6. No Access

    Article

    Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature

    This study examined the pathogenesis of early-onset sarcoidosis (EOS) in a patient with a rare NOD2 mutation and surveyed the literature to identify the hallmark features for early diagnosis. An infant girl suffe...

    Yusuke Takeuchi, Tomonari Shigemura, Norimoto Kobayashi in Clinical Rheumatology (2017)

  7. No Access

    Article

    Baseline low-density lipoprotein cholesterol predicts the hemoglobin A1c-lowering effect of dapagliflozin in Japanese patients with type 2 diabetes mellitus

    Our purpose was to clarify the predictive clinical characteristics of add-on therapy using dapagliflozin in patients with type 2 diabetes mellitus.

    Tomoyuki Iwasaki, Masato Yoneda in Diabetology International (2016)

  8. No Access

    Article

    Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats

    The term nonalcoholic steatohepatitis (NASH) has recently been proposed to identify a fatty liver disease accompanied by diffuse fatty infiltration and inflammation. However, no drug therapy has been established ...

    Koji Fujita, Masato Yoneda, Koichiro Wada in Digestive Diseases and Sciences (2007)

  9. No Access

    Article

    High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

    The changes in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However, it has remained difficult to differentiate between NASH and nonp...

    Masato Yoneda, Hironori Mawatari, Koji Fujita, Hiroshi Iida in Journal of Gastroenterology (2007)

  10. No Access

    Article

    Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

    The changes in nonalcoholic fatty liver disease range over a wide spectrum, extending from simple steatosis to nonalcoholic steatohepatitis (NASH). We investigated the clinical usefulness of the type IV collag...

    Masato Yoneda, Hironori Mawatari, Koji Fujita in Journal of Gastroenterology (2007)

  11. No Access

    Article

    Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?

    Medication for the relief of heartburn should have the rapid onset of action required for on-demand use. We studied the inhibition of gastric acid secretion by lafutidine and rabeprazole, given in single doses...

    Masahiko Inamori, Jun-Ichi Togawa, Tomoyuki Iwasaki in Journal of Gastroenterology (2005)